Different Modalities for the Evaluation of Patients With Peri-menopausal Bleeding
Recruiting
N/A
Interventional Study
Perimenopausal Bleeding
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 55
- Sex
- Female
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 106 (estimated)
- Sponsor
- Sohag University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to compare between 3D ultrasonography and hysteroscopy for the evaluation of cases with Peri-menopausal bleeding
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Any pattern of abnormal uterine bleeding as menorrhagia or metrorrhagia for more than 3 months at age between 40 and 55 years , and no ovarian lesion or local cause of bleeding as vaginal or cervical ulcer
Exclusion Criteria:
* • Women with postmenopausal bleeding.
* System…
Contacts
ahmed abdelrahem fattouh, resident of Obstetrics and Gyn
00201146329946
CONTACT